Form 4: Wave Life Sciences Director Sells Shares
Insider Transaction (Form 4)
Heidi L Wagner, a Director of Wave Life Sciences Ltd., sold 7,000 shares of common stock on August 11, 2026 for $6.01 per share.
Summary
- Option exercise/conversion: acquired 7,000 Common Stock at $5.97 ($41,790) on August 11, 2026; holds 51,930 after (Direct).
- Open-market sale: disposed of 7,000 Common Stock at $6.01 ($42,070) on August 11, 2026; holds 44,930 after (Direct).
- Option exercise/conversion: disposed of 7,000 Stock Option (right to buy) on August 11, 2026 (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $42,070 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Heidi L Wagner — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-11 | Option exercise/conversion | Common Stock | 7,000 | $6 | $41.8K | 51,930 |
| 2026-08-11 | Open-market sale | Common Stock | 7,000 | $6 | $42.1K | 44,930 |
| 2026-08-11 | Option exercise/conversion | Stock Option (right to buy) | 7,000 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-11 | Option exercise/conversion (7,000 shares) |
| 2026-08-11 | Open-market sale (7,000 shares) |
| 2026-08-11 | Option exercise/conversion (7,000 shares) |
Keywords
insider transaction, Form 4, WVE, Wave Life Sciences, Inc., bearish, Heidi L Wagner
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.